ARCHIVES

NSABP Trial Finds Raloxifene Equivalent To Tamoxifen For Cancer Risk Reduction

This article is from The Cancer Letter archive.

Vol. 29 No. 4 | April 28, 2006

Download PDF Visit The Full Archive

Related Articles

Impath Buys Clinical Studies Support Services Network.

September 28, 2001

DCT board Okays Recompetition of Clinical Trials Contracts

October 29, 1993

Two New Organ Systems Working Groups to Be Considered By NCAB

October 4, 1985

As Leadership Changes Continue, Fontaine, Leach Get New Posts

January 17, 2014

NIH Lifts Patient Limit On Gene Modified TIL Study; 6 Treated So Far

April 13, 1990

ACS Adopts Principles As Basis For Reform Of Health Care System

July 17, 1992